← Leaderboards
Eunhee Kim
University Of Texas Hlth Sci Ctr Houston
$1,146,679
Attributed
$1,361,179
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $694K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,361,179 · 2
By mechanism
R01$932,179 · 1
R21$429,000 · 1
Top collaborators
- Peng Roc Chen2 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Eunsu Park$1,509,300
- Angelo Nascimbene$1,822,560
Others in their field
Other Rising Stars on “Family”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Alaina J Harkness · Current Innovation, Nfp$13,724,091
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- April Carson · University Of Mississippi Med Ctr$9,022,104
Research focus
FamilyFunctional DisorderEndothelial CellsEndotheliumAttenuatedArteriesBlood VesselsElectrical ResistanceBrain Arteriovenous MalformationsBrain Endothelial CellBrain HemorrhageCadherin 5CalpainCalpain InhibitorCardiacCaspaseDisabilityCd44 GeneCell PhysiologyCellsCerebral Hemisphere HemorrhageCessation Of LifeCharacteristicsGenes
Grant awards (4)
Endothelial-to-mesenchymal transition in mutant KRAS-induced brain as a cause of arteriovenous malformations$460,023
R01 · FY2025 · NS · contact PI
EndMT as a target to treat human brain arteriovenous malformations$234,000
R21 · FY2025 · NS · contact PI
Endothelial-to-mesenchymal transition in mutant KRAS-induced brain as a cause of arteriovenous malformations$472,156
R01 · FY2024 · NS · contact PI
EndMT as a target to treat human brain arteriovenous malformations$195,000
R21 · FY2024 · NS · contact PI